-
Mashup Score: 4
The UK recently moved to ban smoking for individuals born after 2009 while the US delayed implementation of a ban on menthol cigarettes—again.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Could Precision Oncology Evolve to Treat Cancer Before It Develops? - ILCN.org (ILCN/WCLC) - 3 day(s) ago
Drs. Laila Roisman and Nir Peled envision a future where artificial intelligence elevates personalized medicine in ways once thought impossible.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0ALINA Trial Leads to New Treatment Option for Early-Stage ALK+ NSCLC - ILCN.org (ILCN/WCLC) - 4 day(s) ago
The US approved alectinib as adjuvant treatment based on a significant DFS benefit compared to chemotherapy.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 25Adjuvant Alectinib for ALK+ NSCLC: An Interview with Dr. Benjamin Solomon - ILCN.org (ILCN/WCLC) - 5 day(s) ago
Speaking with Dr. Narjust Florez, Prof. Solomon discusses the design and results of the ALINA trial.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 12Increased Biomarker Uptake Needed to Further Realize Potential of Precision Medicine - ILCN.org (ILCN/WCLC) - 9 day(s) ago
Drs. Christian Rolfo and Valeria Denninghoff contend that data show improvements in outcomes from personalized treatment may have stalled and that increased testing for driver genes alterations is needed.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 57Increased Biomarker Uptake Needed to Further Realize Potential of Precision Medicine - ILCN.org (ILCN/WCLC) - 10 day(s) ago
Drs. Christian Rolfo and Valeria Denninghoff contend that data show improvements in outcomes from personalized treatment may have stalled and that increased testing for driver genes alterations is needed.
Source: www.ilcn.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Regulatory News for April 24, 2024 - ILCN.org (ILCN/WCLC) - 12 day(s) ago
US FDA grants accelerated approval of HER2-targeting antibody drug conjugate; China accepts supplemental new drug application for savolitinib.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 14Can Artificial Intelligence Identify Those at High Risk and Shift the Lung Cancer Screening Paradigm? - ILCN.org (ILCN/WCLC) - 16 day(s) ago
In a recent interview, Dr. Lecia V. Sequist, a member of the team behind the Sybil AI algorithm, discusses how technology may soon be able to predict who will develop lung cancer.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 10MARIPOSA-2 Post-progression Analysis Favors Amivantamab-Chemotherapy Combination - ILCN.org (ILCN/WCLC) - 17 day(s) ago
Compared to chemotherapy alone, the addition of the EGFR-MET bispecific antibody significantly prolonged progression-free survival after subsequent therapy, said Dr. Ryan Gentzler during the European Lung Cancer Congress.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 7
Dr. Jeffrey D. Bradley presented the data from the phase III study of durvalumab in combination with and following chemoradiotherapy for patients with unresectable, stage III NSCLC during the 2024 European Lung Cancer Congress.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
Last month, tobacco control efforts found success in the UK, while US regulations faltered. Learn more in #ILCN: https://t.co/botClrqUA1 #LCSM